Heterociclos con nitrógeno (N)

Please enquire for more information about 1-Boc-4-(4-methoxycarbonylphenyl)piperazine including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about (S)-1-Benzyl 3-ethyl piperidine-1,3-dicarboxylate including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about Ethyl (7-methyl-5-oxo-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-2-yl)acetate including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about 4-Benzyl-1-(2-bromo-2-methylpropanoyl)piperidine including the price, delivery time and more detailed product information at the technical inquiry form on this page

Methyl piperidine-2-carboxylate hydrochloride (MPC) is a molecule that has been studied for its potential anti-inflammatory and anti-cancer properties. MPC is a neurotrophic agent, meaning it stimulates the growth of neurons. It has also been shown to have chemoattractant effects on neutrophils. This compound has been used in animal studies to study bowel disease, cancer, and skin reactions. MPC can be administered topically or orally and has been shown to be effective in reducing inflammation in the bladder. The reaction intermediates, enzyme activities, and eye disorders are not well understood but may be due to the fact that MPC is an enantiomer which can cause stereoisomerism.

1-(Prop-2-yn-1-yl)piperidine is a test compound that can bind to the active site of oxidases and cause them to become irreversibly inhibited, thereby inhibiting the production of reactive oxygen species. It has been shown to be neuroprotective against apoptotic cell death in neuronal cells in culture and also inhibits the growth of cryptococcus neoformans. The binding between 1-(prop-2-yn-1-yl)piperidine and its target is reversible, so it can be used as a drug candidate for treating diseases caused by oxidative stress. The major reaction product formed when 1-(prop-2-yn-1-yl)piperidine interacts with 2,4 dichlorophenolindophenol (DCPIP) is 2,4 dichloroacetic acid (DCA). This reaction product can be detected by chemical ionization mass spectrometry.